Skip to main content
    S

    Spyre Therapeutics Inc. (SYRE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $99.37
    -4.63 (-4.45%)

    Market Cap: $9.88B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Spyre Therapeutics Inc. (SYRE) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Spyre Therapeutics are TG Therapeutics (TGTX), Apogee Therapeutics, Inc. Common Stock (APGE) and Kymera Therapeutics (KYMR). By market cap, Spyre Therapeutics ranks 6th of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B. The median P/E of the 4 companies with a P/E is 40.0x.

    Peer Comparison

    SYRE's revenue growth of 0.0% is below the peer median of 41.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Spyre Therapeutics (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Apogee Therapeutics, Inc. Common Stock (APGE)$10.22BN/AN/A0.0%N/A0.0%0.00%
    Kymera Therapeutics Inc (KYMR)$10.89BN/A123.2x0.0%N/A466.4%0.00%
    Summit Therapeutics PLC (SMMT)$11.32BN/AN/A0.0%N/A-100.0%0.00%
    Protagonist Therapeutics Inc (PTGX)$8.55B27.7x15.8x62.0%N/A5724.0%0.00%
    Praxis Precision Medicines Inc (PRAX)$9.17BN/AN/A0.0%N/A1349.0%0.00%
    Axsome Therapeutics Inc (AXSM)$7.45BN/A8.6x-18.2%-48.1%51.9%0.00%
    Krystal Biotech Inc (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    Abivax SA American Depositary Shares (ABVX)$7.67BN/AN/A0.0%-159.6%-6.8%0.00%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    Twist Bioscience Corp (TWST)$7.40BN/A14.3x-28.3%N/A27.9%0.00%
    Bio-Techne Corp (TECH)$11.44B39.6x9.3x14.0%7.7%4.6%0.44%
    Peer median$9.46B40.0x15.0x0.0%-33.0%41.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Spyre Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Apogee Therapeutics, Inc. Common Stock (APGE)
    Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)...
    Kymera Therapeutics Inc (KYMR)
    Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down...
    KYMR competitors
    Summit Therapeutics PLC (SMMT)
    Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America...
    SMMT competitors
    Protagonist Therapeutics Inc (PTGX)
    Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical...
    PTGX competitors
    Praxis Precision Medicines Inc (PRAX)
    Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal...
    PRAX competitors
    Axsome Therapeutics Inc (AXSM)
    Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United...
    AXSM competitors
    Krystal Biotech Inc (KRYS)
    Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United...
    KRYS competitors
    Abivax SA American Depositary Shares (ABVX)
    Abivax SA is a clinical-stage biotechnology firm focused on pioneering immunotherapies for chronic inflammatory diseases and viral infections.
    ABVX competitors
    BridgeBio Pharma Inc (BBIO)
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors
    Twist Bioscience Corp (TWST)
    Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products.
    TWST competitors
    Bio-Techne Corp (TECH)
    Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments...
    TECH competitors

    Frequently Asked Questions About SYRE

    Who are Spyre Therapeutics' main competitors?

    The companies most similar to Spyre Therapeutics include TG Therapeutics (TGTX), Apogee Therapeutics, Inc. Common Stock (APGE), Kymera Therapeutics (KYMR), Summit Therapeutics (SMMT) and Protagonist Therapeutics (PTGX), listed from the closest match.

    Who is Spyre Therapeutics' biggest competitor?

    BridgeBio Pharma (BBIO) is the largest of the similar companies at $15.25B; TG Therapeutics (TGTX) is the closest match by business profile, size, sector and industry.

    How does SYRE stock compare with its competitors?

    SYRE's net margin is 0.0% against a peer median of 0.0%.

    Which of Spyre Therapeutics' competitors pays a higher dividend?

    Spyre Therapeutics pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.

    Is Spyre Therapeutics bigger than its competitors?

    No. Spyre Therapeutics is 6th by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.